Institute for Molecular Medicine Finland, HiLIFE
Building a bridge from discovery to medicine
OUR MISSION: FIMM is a translational institute with a driving mission to perform innovative research on patients and populations - utilizing molecular, genomic and health data – targeted towards understanding drivers of health and disease and delivering improvements to the safety, efficacy and efficiency of healthcare in Finland and beyond.
An international collaboration uncovers several genetic markers associated with SARS-CoV-2 infection and COVID-19 severity.
FinnGen research results integrated into Open Targets Genetics
Open Targets is an innovative, large-scale public-private partnership that uses human genetics and genomics data for systematic drug target...
Insights into how to better understand and treat COVID-19 are desperately needed. This page summarizes the FIMM efforts in contributing our researchers' expertise, technology and time to help to beat the COVID-19 pandemic.